This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of prostate cancer Prostate cancer is the most common cancer in males and radiation therapy is a major tool in the management of the disease. This issue of Radiation Medicine Rounds includes reviews of all major recent advances in treatment of favorable, intermediate and high-risk prostate cancer as well as newer modalities such as brachytherapy, stereotactic body radiation therapy, and proton beam radiotherapy. Articles also review current knowledge in the areas of new biomarkers, risk stratification, and risk stratification. This issue of RMR will provide the practitioner with a full current overview of the present best practices and recent research in management of this complex and challenging disease.
Radiation Medicine Rounds features:
In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine
Each issue edited by an authority in that subject area
Each issue focused on a single major topic in Radiation Medicine, providing coverage of advances in radiation science, radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcome studies
1.New Biomarkers in Prostate Cancer: A Radiation Oncology Perspective 2. Risk Stratification in Nonmetastatic Prostate Cancer: Implications for Treatment, 3. Treatment of Favorable- Risk Prostate Cancer, 4. Intermediate Risk Prostate Cancer: Role of Androgen Deprivation, 5. High-Risk Prostate Cancer 6 Duration and Timing of Neoadjuvant/Adjuvant Androgen Deprivation in Nonmetastatic Prostate Caner, 7. Current Role of Salvage and Adjuvant Radiotherapy for Prostate Cancer, 8. Prostate Brachytherapy, 9. Stereotactic Body Radiation for Prostate Cancer, 10. Proton Therapy for the Treatment of Prostate Cancer, 11. Image-Guided Strategies for Prostate Cancer, 12. Treatment of Intermediate-Risk Prostate Cancer , 13. Chemoprevention in Prostate Cancer: Current Clinical Evidence, 14. Quality-of-Life Issues in the Radiotherapeutic Management of Localized Prostate Cancer